Patents by Inventor Steven Diaz

Steven Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120232149
    Abstract: A solid pharmaceutical composition containing pregabalin is described. The composition includes a matrix forming agent and a swelling agent and is suitable for once daily oral administration. Exemplary matrix forming agents include mixtures of polyvinyl acetate and polyvinylpyrrolidone, and exemplary swelling agents include cross-linked polymers of polyvinylpyrrolidone.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 13, 2012
    Applicant: Warner-Lambert Company LLC
    Inventors: Howard N. Bockbrader, Yun Hyung Cho, Steven Diaz Santiago, Majid Mahjour, Thomas Daniel Reynolds, Pushpa Ganapathi Shao, Zezhi Jesse Shao, Jiansheng Wan
  • Publication number: 20120029081
    Abstract: A solid pharmaceutical composition containing pregabalin is described. The composition includes a matrix forming agent and a swelling agent and is suitable for once daily oral administration. Exemplary matrix forming agents include mixtures of polyvinyl acetate and polyvinylpyrrolidone, and exemplary swelling agents include cross-linked polymers of polyvinylpyrrolidone.
    Type: Application
    Filed: October 6, 2011
    Publication date: February 2, 2012
    Applicant: Warner-Lambert Company LLC
    Inventors: Howard N. Bockbrader, Yun Hyung Cho, Steven Diaz Santiago, Majid Mahjour, Thomas Daniel Reynolds, Pushpa Ganapathi Shao, Zezhi Jesse Shao, Jiansheng Wan
  • Publication number: 20100183716
    Abstract: Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV.
    Type: Application
    Filed: June 20, 2008
    Publication date: July 22, 2010
    Inventors: Otilia May Koo, Faranak Nikfar, Steven Diaz
  • Publication number: 20100183715
    Abstract: Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV.
    Type: Application
    Filed: June 20, 2008
    Publication date: July 22, 2010
    Inventors: Otilia May Koo, Faranak Nikfar, Steven Diaz
  • Publication number: 20100178339
    Abstract: Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV.
    Type: Application
    Filed: June 20, 2008
    Publication date: July 15, 2010
    Inventors: Otilia May Koo, Faranak Nikfar, Steven Diaz
  • Publication number: 20100178340
    Abstract: Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV.
    Type: Application
    Filed: June 20, 2008
    Publication date: July 15, 2010
    Inventors: Otilia May Koo, Faranak Nikfar, Steven Diaz
  • Publication number: 20070269511
    Abstract: A solid pharmaceutical composition containing pregabalin is described. The composition includes a matrix forming agent and a swelling agent and is suitable for once daily oral administration. Exemplary matrix forming agents include mixtures of polyvinyl acetate and polyvinylpyrrolidone, and exemplary swelling agents include cross-linked polymers of polyvinylpyrrolidone.
    Type: Application
    Filed: November 2, 2006
    Publication date: November 22, 2007
    Applicant: WARNER-LAMBERT COMPANY LLC
    Inventors: Howard Bockbrader, Yun Cho, Steven Diaz Santiago, Majid Mahjour, Thomas Reynolds, Pushpa Shao, Zezhi Shao, Jiansheng Wan